Pam focuses her practice on defending companies and individuals in government investigations involving white collar and regulatory matters.  She has conducted numerous investigations for multinational organizations throughout the world. She is currently leading investigative teams throughout Asia, South America, South Africa and North America that require the use of Orrick's global resources in China, Hong Kong, the United Kingdom and the United States. Pam has been selected two times by the SEC and DOJ as an FCPA Monitor, involving a medical device company and a banking technology company.  Pam gained the unique distinction of being selected three times by the U.S. government to serve as an independent FCPA monitor when she was recently selected by the SEC as the Independent Compliance Consultant for a separate medical device company. 

In addition to her investigative practice, Pam conducts global reviews of existing compliance plans, FCPA Policies and Global Codes of Ethics, as well as due diligence associated with M&A work. She assists clients in revising existing FCPA and Global Codes of Ethics to fit today's heightened focus on anticorruption legislation. In addition to her significant work on FCPA related and global investigation matters, she also continues to represent companies and individuals in connection with a variety of other matters, including, health care fraud, antitrust offenses, securities fraud, trade secrets theft allegations, securities and export violations, mail and wire fraud, and environmental cases. Additionally, when a matter cannot, or should not be settled, she has substantial trial and courtroom experience in broad-based U.S. state and federal criminal matters, and related civil litigation, including more than 50 jury and court trials.

  • Before joining Orrick, Pam worked as a partner at DLA Piper Rudnick Gray Cary LLP. Before that, she was a Deputy District Attorney for the County of Contra Costa.

    She has been selected as a Northern California Super Lawyer in White Collar Criminal Defense 2012-2017.

    Pam currently serves on the on the BASF Criminal Executive Committee.

  • The following is a sample of Pam's experience.

    • Currently serving as the SEC appointed Independent FCPA Compliance Consultant for a medical device company. 
    • Selected twice by the SEC and DOJ as an Independent FCPA Monitor for a banking technology company and a medical device company.
    • Conducted FCPA due diligence in M&A transactions, including issuing an FCPA opinion in a cross-border Russian acquisition.
    • Multiple representations of audit and special committees in internal investigations involving alleged violations of the FCPA throughout the world, including China, India, South America, Europe and Mongolia.
    • Developed multiple FCPA policies, global code of ethics and compliance training materials, in multiple industries, including: clean fuel, medical devices sales and manufacturing, consumer retail products, construction equipment, on-line auctions, global supply chain and inventory management providers and social media.
    • Representation of the former Controller to a U.S. public entity in conjunction with a DOJ/SEC FCPA investigation.
    • Representation of the former Director of Marketing of Genentech in connection with civil False Claims Act litigation.
    • Representation of former executives and employees of a Fortune 100 pharmaceutical company in connection with an investigation by the San Francisco United States Attorney's Office, and related civil proceedings, concerning allegations of off label marketing of a heart failure drug.
    • Representation of the former President of Countrywide Financial Corporation, the nation's largest mortgage lender, in connection with investigations by and litigation with the California Attorney General, and related consumer class and individual actions.
    • Representation of a durable medical equipment company in connection with criminal and civil investigation by the California Attorney General concerning billing practices.
    • Representation of a health care service provider and physician in connection with health care fraud investigation.
    • Representation of a medical device company in connection with allegations regarding the FCPA.
    • Prosecution of claims of misappropriation of trade secrets, conversion and breach of contract involving computer telephony subsystems and components.
    • Representation of a senior executive charged with price fixing/antitrust violations in the telecommunications industry.
    • Representation of a senior executive of Samsung Semiconductor, Inc., charged with criminal price fixing/antitrust violations in the DRAM industry.
    • Representation of numerous companies and individuals in connection with insider trading and other securities fraud investigations (civil and criminal).
    • Representation of a power generator in connection with the California Attorney General's investigation of alleged market manipulation arising out of California's energy crisis.
    • Representation of a major computer manufacturer in connection with allegations of exporting computers to Russia without a license.
    • Representation of corporate victims of trade secrets theft, including investigation of wrongdoing and advocacy of victims' interests before federal and state law enforcement officials.
    • Representation of a defense contractor in connection with investigation into alleged false statements pertaining to government contracts.
    • Representation of employers and supervisors in connection with investigations of alleged criminal OSHA violations arising out of industrial accidents.
    • Representation of an audit committee in an internal investigation in connection with stock option backdating allegations.

Insights